Morgan Stanley analyst Erin Wright lowered the firm’s price target on Patterson Companies to $28 from $30 and keeps an Equal Weight rating on the shares. Expectations were low into the print, and while the Q4 operational miss underscores the challenging dental backdrop and is viewed as disappointing, initial FY25 EPS is perceived as better than feared, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PDCO:
- Patterson Companies sees FY25 adjusted EPS $2.33-$2.43, consensus $2.39
- Patterson Companies reports Q4 EPS 82c, consensus 82c
- Options Volatility and Implied Earnings Moves Today, June 18, 2024
- Options Volatility and Implied Earnings Moves This Week, June 17 – June 21, 2024
- PDCO Earnings Report this Week: Is It a Buy, Ahead of Earnings?